Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Grace Nevil, Michael Roth, Jonathan Gill, Wendong Zhang, Beverly Teicher, Stephen W. Erickson, Gregory Gatto, Malcom Smith, E. Anders Kolb & Richard Gorlick. (2021) Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium. Pediatric Hematology and Oncology 38:1, pages 8-13.
Read now
Read now
Mindy M. Hugo & Ipsita A. Banerjee. (2019) Development of new amphiphilic bio-organic assemblies for potential applications in iron-binding and targeting tumor cells. Soft Materials 17:1, pages 57-76.
Read now
Read now
DeborahL. Ornstein & LeoR. Zacharski. (2007) Iron Stimulates Urokinase Plasminogen Activator Expression and Activates NF-kappa B in Human Prostate Cancer Cells. Nutrition and Cancer 58:1, pages 115-126.
Read now
Read now
Articles from other publishers (31)
Tharushi P. Wijesinghe, Mahendiran Dharmasivam, Charles C. Dai & Des R. Richardson. (2021) Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc. Pharmacological Research 173, pages 105889.
Crossref
Crossref
You Jung Kang, Claire K. Holley, Mohammad Reza Abidian, Achuthamangalam B. Madhankumar, James Connor & Sheereen Majd. (2020) Tumor Targeted Delivery of an Anti‐Cancer Therapeutic: An In Vitro and In Vivo Evaluation. Advanced Healthcare Materials 10:2, pages 2001261.
Crossref
Crossref
Claire K. Holley, You Jung Kang, Chung-Fan Kuo, Mohammad Reza Abidian & Sheereen Majd. (2019) Development and in vitro assessment of an anti-tumor nano-formulation. Colloids and Surfaces B: Biointerfaces 184, pages 110481.
Crossref
Crossref
Claire K. Holley, Bridgett Sinquefield & Sheereen Majd. (2019) Optimization of the Single Emulsion Method for Encapsulation of a Cancer Drug in Nanoparticles. Optimization of the Single Emulsion Method for Encapsulation of a Cancer Drug in Nanoparticles.
Y.J. Kang, C-F. Kuo & S. Majd. (2017) Nanoparticle-based delivery of an anti-proliferative metal chelator to tumor cells. Nanoparticle-based delivery of an anti-proliferative metal chelator to tumor cells.
Zhongjie Xu, Youxun Liu, Sufeng Zhou, Yun Fu & Changzheng Li. (2016) Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques. International Journal of Molecular Sciences 17:7, pages 1042.
Crossref
Crossref
Cuiping Li, Tengfei Huang, Yun Fu, Youxun Liu, Sufeng Zhou, Zhangyang Qi & Changzheng Li. (2016) Interaction of Di-2-pyridylketone 2-pyridine Carboxylic Acid Hydrazone and Its Copper Complex with BSA: Effect on Antitumor Activity as Revealed by Spectroscopic Studies. Molecules 21:5, pages 563.
Crossref
Crossref
Ufuk ÖZER. (2016) Copper enriches efficacy of Dp44mT in breast cancer cells. TURKISH JOURNAL OF BIOLOGY 40, pages 1185-1191.
Crossref
Crossref
YINGLI YANG, TENGFEI HUANG, SUFENG ZHOU, YUN FU, YOUXUN LIU, YANBIN YUAN, QIONGQING ZHANG, SHAOSHAN LI & CHANGZHENG LI. (2015) Antitumor activity of a 2-pyridinecarboxaldehyde 2-pyridinecarboxylic acid hydrazone copper complex and the related mechanism. Oncology Reports 34:3, pages 1311-1318.
Crossref
Crossref
Lawrence D. HorwitzMarcus A. Horwitz. (2014) The Exochelins of Pathogenic Mycobacteria: Unique, Highly Potent, Lipid- and Water-Soluble Hexadentate Iron Chelators with Multiple Potential Therapeutic Uses. Antioxidants & Redox Signaling 21:16, pages 2246-2261.
Crossref
Crossref
Junye Zhang, Lei Cui, Minhua Xu & Yuanli Zheng. (2014) Restoring the Secretory Function of Irradiation-Damaged Salivary Gland by Administrating Deferoxamine in Mice. PLoS ONE 9:11, pages e113721.
Crossref
Crossref
Kimiko Ishiguro, Z. Ping Lin, Philip G. Penketh, Krishnamurthy Shyam, Rui Zhu, Raymond P. Baumann, Yong-Lian Zhu, Alan C. Sartorelli, Thomas J. Rutherford & Elena S. Ratner. (2014) Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes. Biochemical Pharmacology 91:3, pages 312-322.
Crossref
Crossref
Oriana Marques, Berta Martins da Silva, Graça Porto & Carlos Lopes. (2014) Iron homeostasis in breast cancer. Cancer Letters 347:1, pages 1-14.
Crossref
Crossref
Huangtao Jin, Zhongyu Xu, Dongfeng Li & Jin Huang. (2014) Antiproliferative activity and therapeutic implications of potassium tris(4-methyl-1-pyrazolyl) borohydride in hepatocellular carcinoma. Chemico-Biological Interactions 213, pages 69-76.
Crossref
Crossref
Yun Fu, Sufeng Zhou, Youxun Liu, Yingli Yang, Xingzhi Sun & Changzheng Li. (2014)
The Cytotoxicity of Benzaldehyde Nitrogen Mustard-2-Pyridine Carboxylic Acid Hydrazone Being Involved in Topoisomerase II
?
Inhibition
. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Angelica M. MerlotDanuta S. KalinowskiDes R. Richardson. (2013) Novel Chelators for Cancer Treatment: Where Are We Now?. Antioxidants & Redox Signaling 18:8, pages 973-1006.
Crossref
Crossref
David B. Lovejoy, Danae M. Sharp, Nicole Seebacher, Peyman Obeidy, Thomas Prichard, Christian Stefani, Maram T. Basha, Philip C. Sharpe, Patric J. Jansson, Danuta S. Kalinowski, Paul V. Bernhardt & Des R. Richardson. (2012) Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo. Journal of Medicinal Chemistry 55:16, pages 7230-7244.
Crossref
Crossref
Michael RothBritta WillGuillermo SimkinSwathi NarayanagariLaura BarreyroBoris BartholdyRoni TamariConstantine S. MitsiadesAmit Verma & Ulrich Steidl. (2012) Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood 120:2, pages 386-394.
Crossref
Crossref
Robert L. Elliott & Jonathan F. Head. (2012) Cancer: Tumor Iron Metabolism, Mitochondrial Dysfunction and Tumor Immunosuppression; “A Tight Partnership—Was Warburg Correct?”. Journal of Cancer Therapy 03:04, pages 278-311.
Crossref
Crossref
B. Poljsak & I. Milisav. (2012) The Neglected Significance of “Antioxidative Stress”. Oxidative Medicine and Cellular Longevity 2012, pages 1-12.
Crossref
Crossref
Steven Minear, Allyson F. O'Donnell, Anna Ballew, Guri Giaever, Corey Nislow, Tim Stearns & Martha S. Cyert. (2011) Curcumin Inhibits Growth of Saccharomyces cerevisiae through Iron Chelation. Eukaryotic Cell 10:11, pages 1574-1581.
Crossref
Crossref
David B. Lovejoy, Patric J. Jansson, Ulf T. Brunk, Jacky Wong, Prem Ponka & Des R. Richardson. (2011) Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes. Cancer Research 71:17, pages 5871-5880.
Crossref
Crossref
Angelica M. Merlot, Namfon Pantarat, David B. Lovejoy, Danuta S. Kalinowski & Des R. Richardson. (2010) Membrane Transport and Intracellular Sequestration of Novel Thiosemicarbazone Chelators for the Treatment of Cancer. Molecular Pharmacology 78:4, pages 675-684.
Crossref
Crossref
Heather C Hatcher, Ravi N Singh, Frank M TortiSuzy V Torti. (2009) Synthetic and natural iron chelators: therapeutic potential and clinical use. Future Medicinal Chemistry 1:9, pages 1643-1670.
Crossref
Crossref
Douglas B Kell. (2009) Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Medical Genomics 2:1.
Crossref
Crossref
D.R. Richardson, D.S. Kalinowski, S. Lau, P.J. Jansson & D.B. Lovejoy. (2009) Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:7, pages 702-717.
Crossref
Crossref
Michael K. Kiessling, Claus D. Klemke, Marcin M. Kamiński, Ioanna E. Galani, Peter H. Krammer & Karsten Gülow. (2009) Inhibition of Constitutively Activated Nuclear Factor-κB Induces Reactive Oxygen Species- and Iron-Dependent Cell Death in Cutaneous T-Cell Lymphoma. Cancer Research 69:6, pages 2365-2374.
Crossref
Crossref
Egarit Noulsri, Des R. Richardson, Surada Lerdwana, Suthat Fucharoen, Tetsuo Yamagishi, Danuta S. Kalinowski & Kovit Pattanapanyasat. (2009) Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells. American Journal of Hematology 84:3, pages 170-176.
Crossref
Crossref
S. Defrere, J.C. Lousse, R. Gonzalez-Ramos, S. Colette, J. Donnez & A. Van Langendonckt. (2008) Potential involvement of iron in the pathogenesis of peritoneal endometriosis. Molecular Human Reproduction 14:7, pages 377-385.
Crossref
Crossref
Karin Merschjohann & Dietmar Steverding. (2006) In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolenseby iron chelators. Kinetoplastid Biology and Disease 5:1.
Crossref
Crossref
Sylvie Defrère, Anne Van Langendonckt, Sophie Vaesen, Mathieu Jouret, Reinaldo González Ramos, Dolores Gonzalez & Jacques Donnez. (2006) Iron overload enhances epithelial cell proliferation in endometriotic lesions induced in a murine model. Human Reproduction 21:11, pages 2810-2816.
Crossref
Crossref